Knarik Arkun

2.5k citations
49 papers · 1.7k indexed · 1 hit paper · h-index 12

Knarik Arkun

45 papers receiving 1.7k citations

Hit Papers

Acquired Resistance to Imatinib in Gastrointestinal Strom...6332005202620122019200400600

Peers

Knarik Arkun
Comparison fields: 5 of 93
  • Gastroenterology 504
  • Hematology 331
  • Obstetrics and Gynecology 202
  • Immunology 463
  • Neurology 233
Replace Kenneth Tou En Chang with:
Kenneth Tou En Chang Singapore
Sergio Peralta Italy
Marzena Olesińska Poland
Francesca Schena Italy
J. M. A. Whitehouse United Kingdom
Janet K. Stephens United States
J E Salmon United States
Fritz Lin United States
Angela Ceribelli Italy
Morris Edelman United States
Knarik Arkun relative to Kenneth Tou En Chang Singapore Kenneth Tou En Chang's profile →
Citations per field
00.5×5.9×
Kenneth Tou En Chang · 1×
Citations per year

Countries citing papers authored by Knarik Arkun

Since Specialization
Citations

This map shows the geographic impact of Knarik Arkun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knarik Arkun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knarik Arkun more than expected).

Fields of papers citing papers by Knarik Arkun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knarik Arkun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knarik Arkun. The network helps show where Knarik Arkun may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Knarik Arkun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Knarik Arkun Line = papers co-authored together Knarik Arkun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20231
4 20223
5 20226
6 202210
7 20221
8 20214
9 202125
10 202010
11 202014
12 202015
13 20204
14 2020298
15 20190
16 201986
17 20190
18 20163
19 20101
20 200615

About Knarik Arkun

Knarik Arkun is a scholar working on Genetics, Nephrology and Rheumatology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers), Glioma Diagnosis and Treatment (4 papers), Parathyroid Disorders and Treatments (4 papers), Meningioma and schwannoma management (4 papers), Cardiovascular Function and Risk Factors (3 papers), Ear and Head Tumors (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). The work is most often cited by research in Gastroenterology (504 citations), Hematology (331 citations) and Obstetrics and Gynecology (202 citations). Knarik Arkun has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Ronald P. DeMatteo, Cristina R. Antonescu, Peter Besmer, Tianhua Guo, Samuel Singer, Margaret Leversha, Murray F. Brennan, Robert G. Maki, Philip D. Jeffrey and Bo Dupont. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026